Baylor Miraca Genetics Laboratories LLC
UEI HV15NRPPNU25 · TX · SAM.gov record ↗
$11.8M
FY2025 obligations
5
Contract awards
Sep 24, 2024
First action
May 6, 2026
Latest action
Obligations by agency
- Department Of Veterans Affairs$10.7M
- Department Of Health And Human Services$1.0M
- Department Of Defense$77K
Obligations by NAICS
Monthly obligations
Oct 24
Dec 24
Mar 25
Apr 25
Jun 25
Jul 25
Sep 25
Dec 25
May 26
Contracts ending within 18 months (recompete watch)
- 75N93024P01210 ↗$777K
1400 PHARMACOGENOMIC ALLELE CALLS
- Ends
- Sep 23, 2026
- Started
- Sep 24, 2024
- Agency
- National Institutes Of Health
- NAICS
- 541380
- 75N92025P00388 ↗$232K
CLINICAL TESTING
- Ends
- Sep 27, 2026
- Started
- Sep 28, 2025
- Agency
- National Institutes Of Health
- NAICS
- 621511
- 36C10X25N0264 ↗$11.4M
GERMLINE PGX MOLECULAR TESTING - YEAR 2
- Ends
- Sep 28, 2026
- Started
- Sep 29, 2025
- Agency
- Department Of Veterans Affairs
- NAICS
- 621511
- HT941024P0282 ↗$77K
REFERENCE LABORATORY TESTING
- Ends
- Sep 29, 2026
- Started
- Sep 30, 2024
- Agency
- Defense Health Agency
- NAICS
- 621511
| PIID | Description | Agency | NAICS | Obligated | Start | End |
|---|---|---|---|---|---|---|
| 75N93024P01210 ↗ | 1400 PHARMACOGENOMIC ALLELE CALLS | National Institutes Of Health | 541380 | $777K | Sep 24, 2024 | Sep 23, 2026 |
| 75N92025P00388 ↗ | CLINICAL TESTING | National Institutes Of Health | 621511 | $232K | Sep 28, 2025 | Sep 27, 2026 |
| 36C10X25N0264 ↗ | GERMLINE PGX MOLECULAR TESTING - YEAR 2 | Department Of Veterans Affairs | 621511 | $11.4M | Sep 29, 2025 | Sep 28, 2026 |
| HT941024P0282 ↗ | REFERENCE LABORATORY TESTING | Defense Health Agency | 621511 | $77K | Sep 30, 2024 | Sep 29, 2026 |
Largest awards
- 36C10X25N0264 ↗$11.4M
GERMLINE PGX MOLECULAR TESTING - YEAR 2
- Ends
- Sep 28, 2026
- Started
- Sep 29, 2025
- Agency
- Department Of Veterans Affairs
- NAICS
- 621511
- 75N93024P01210 ↗$777K
1400 PHARMACOGENOMIC ALLELE CALLS
- Ends
- Sep 23, 2026
- Started
- Sep 24, 2024
- Agency
- National Institutes Of Health
- NAICS
- 541380
- 75N92025P00388 ↗$232K
CLINICAL TESTING
- Ends
- Sep 27, 2026
- Started
- Sep 28, 2025
- Agency
- National Institutes Of Health
- NAICS
- 621511
- HT941024P0282 ↗$77K
REFERENCE LABORATORY TESTING
- Ends
- Sep 29, 2026
- Started
- Sep 30, 2024
- Agency
- Defense Health Agency
- NAICS
- 621511
- 36C10X24N0226 ↗$-638K
SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE
- Ends
- Sep 28, 2025
- Started
- Sep 29, 2024
- Agency
- Department Of Veterans Affairs
- NAICS
- 621511
| PIID | Description | Agency | NAICS | Obligated | Start | End |
|---|---|---|---|---|---|---|
| 36C10X25N0264 ↗ | GERMLINE PGX MOLECULAR TESTING - YEAR 2 | Department Of Veterans Affairs | 621511 | $11.4M | Sep 29, 2025 | Sep 28, 2026 |
| 75N93024P01210 ↗ | 1400 PHARMACOGENOMIC ALLELE CALLS | National Institutes Of Health | 541380 | $777K | Sep 24, 2024 | Sep 23, 2026 |
| 75N92025P00388 ↗ | CLINICAL TESTING | National Institutes Of Health | 621511 | $232K | Sep 28, 2025 | Sep 27, 2026 |
| HT941024P0282 ↗ | REFERENCE LABORATORY TESTING | Defense Health Agency | 621511 | $77K | Sep 30, 2024 | Sep 29, 2026 |
| 36C10X24N0226 ↗ | SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | Department Of Veterans Affairs | 621511 | $-638K | Sep 29, 2024 | Sep 28, 2025 |